ArticlesArchiveAboutEditorial BoardAuthor Guidelines
Call for papersThe 2026 special issue on Climate & Health is open for submissions.Learn more
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En…
Tamás Kullmann, Dóra Füzi, Tamás Pintér
Background: Neutropenic sepsis is a frequent complication of cytotoxic chemotherapy delivered for cancer patients . Its management is well determined by clinical guidelines. Non-neutropenic sepsis is another potential complication in cancer patients. Its mana…
Kenji Ina, Megumi Kabeya, Shu Yuasa, Yuko Kato, Satoshi Kayukawa, Takae Kataoka, Ryuichi Furuta
Backgrounds: Colorectal cancer is an important contributor to cancer morbidity and mortality. Given that many older adult patients often have concomitant diseases and impairments in organ function, they are at increased risk for chemotherapy toxicity. Therefo…
Samir Eid, Hoda Hasan, Doaa Abdel-Aleem, Amal Rayan
Background and aim : The prognostic role of neutrophil to lymphocyte ratio (NLR) has been shown in many solid tumors included in a recent meta-analysis of one hundred studies. We aimed to evaluate the prognostic value of neutrophil to lymphocyte ratio in trea…
Oren Raz, Ahmad Fahham, Nona Kuchina, Zvi Bentwich, Guy Cohen
Skin cancer, including both melanoma and non-melanoma, is the most common type of malignancy, which causes substantial morbidities and mortalities. Although the significant increase in the understanding of skin cancer formation and the development of novel pe…
A. S. Kone, A. Diakite, I. M. Diarra, K. Diabate, M. A. Camara, Y. L. Diallo, S. Sidibe
Breast cancer is a major public health problem because of its incidence and mortality. Purpose: To establish the epidemiological and clinical characteristics of breast cancer seen at the radiotherapy center at the Mali Hospital of Bamako. Patients and methods…
Haytham Gareer, Waheed Yousry Gareer, Alaadin Hussien
Background and goals Sexual dysfunction is a well-documented complication of rectal cancer surgery, with a reported incidence of 18% - 59%. The objective of this study is to evaluate the incidence of sexual dysfunction (SD) in males after radical resection fo…
G. Yared, J. Darido, R. Chahine, J. Khadra, R. Bachnak, R. Bou Ghanem, K. Dimashkie, M. Kharroubi, I. Farhat, I. Hatoum
Parasitic Leiomyoma (PL) is considered a rare variant of uterine fibroids occurring outside the uterus. We hereby report a challenging case of parasitic leiomyoma that is considered rare in the literature with all its particularities. A 62 YO lady is known to…
J. Darido, S. El Daou, R. El Assaad, A. Fakih, M. Dagher, A. Safa, N. Haddad, H. Farhat
Giant fibroadenomas are exceptional in pregnancy and in most of cases , diameter doesn’t reach more than 15 cm. However, our case is a rare one that reached 18 cm in a 23 - year - old female referred post-partum for evaluation of a huge left breast mass. On t…
Dimitrios-Athanasios Ntanovasilis, Panagiotis Apostolou, Ioannis Papasotiriou
Circulating tumor cells are cells that detach from the primary tumor site and migrate to the bone marrow or other tissues where they can initiate a metastatic site. Liquid biopsies are an emerging tool in the past decades that enables us to detect Circulating…
Julien Bermudez, Celine Mascaux, Youssef Trigui, Julie Biemar, Mohamed Boucekine, Laurent Greillier, Fabrice Barlesi, Pascale Tomasini
Background: Immune checkpoint inhibitors (ICI)s were recently approved for the treatment of advanced non-small cell lung cancer (NSCLC). Whereas brain metastases (BM) are frequent in NSCLC patients, data are missing regarding ICIs intracranial efficacy and to…
No articles in this issue.
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En… All articles are open access under a CC BY 4.0 licence, with authors retaining copyright.
Authors submit their manuscript, metadata, and declarations through the portal. There is no submission fee.
The editorial office screens the manuscript for scope, completeness, and formatting before assigning a handling editor.
At least two independent reviewers evaluate the manuscript under single-blind review. Where revisions are required, authors respond point by point.
On acceptance the article processing charge is invoiced and the CC BY 4.0 copyright handover is signed.
The article is copyedited, typeset, and given a DOI, then publishes open access with a permanent link.
Manuscripts must be original and not under consideration elsewhere. Submit in Microsoft Word or LaTeX with figures at 300 dpi minimum. Structure research articles as Abstract, Introduction, Methods, Results, Discussion, and References.
Use the journal's numbered (Vancouver) reference style. Cite sources consecutively in the order they appear, and ensure every reference is complete and retrievable.
Declare all funding sources, conflicts of interest, and ethical approvals (including informed consent and animal-care statements where applicable).